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Abstract (150 words) 
 
The use of transgenic plants as delivery system for antigenic proteins is attractive for its simplicity and 
increases likelihood for local immune response at sites of infection. The aim of this study was to evaluate the 
protective effect of oral administration of tobacco seeds, expressing the FedA, the major protein of the F18 
adhesive fimbriae,  and B subunit of verocitoxin, against verocytotoxin-producing E. coli (VTEC) strain in 
piglets. Forty-three early weaned piglets, were randomly divided into 4 experimental groups: 3 test groups 
and a control. Treatment groups orally received a bolus, with different dose of tobacco seeds on 0, 1, 2, 14 
days post primary administration. After challenge, with 1*1010 CFU of O138 Escherichia coli strain, piglets 
showed clinical scores significantly higher in the control group compared to orally immunized groups 
(P<0.05) and the latter showed a faster recovery than in CG. In conclusion, oral administration of 
recombinant tobacco seeds expressing antigenic proteins against VTEC strains can induce a protective effect 
against challenger strain in piglets. 
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Introduction 
 
The verocytotoxin-producing E. coli (VTEC) group is composed by E. coli strains capable of producing 
toxins very similar to the one produced by Shigella dysenteriae. In human the Shiga toxins produced by E. 
coli may cause anything from uncomplicated diarrhoea to haemorrhagic colitis, which can progress into 
haemolytic uremic syndrome, composed of a micro-angiopathic haemolytic anaemia, thrombocytopenia and 
severe acute renal failure requiring intensive care (Ruggenti and Remuzzi, 2012). In pig livestock VTEC 
strains, belonging to serogroups O138, O139, and O141 (Nagy and Fekete, 2005), are responsible for 
important economic losses and may cause different disorders such as Oedema disease (OD),  a systemic 
disease that usually occurs in piglets shortly after weaning (mainly within the first 2 weeks post-weaning) 
and causes high morbidity, mortality and reduction of growth rates. Clinical signs of VTEC infections 
include palpebral oedema, neurological symptoms (i.e. ataxia, paralysis), recumbency, sudden death.  The 
aetiology of the disease is complex, since changes on food composition and consistency, loss of passive 
protection from the sow and genetic susceptibility of the pigs are involved in the pathogenesis (Imberechts et 
al. 1992). The most important symptoms are related to Shiga toxin 2e (Stx2e or VT2e). VT2e toxins are 
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bipartite 70-kDa proteins composed of a single enzymatically active A subunit and five B subunits, 
responsible for binding the toxin to the cell surface. It has been shown that purified VT2e injected 
intravenously in pigs reproduces all the clinical signs and pathological lesions of OD (Macleod et al. 1991) 
and is therefore an important virulence factor. The VTEC strains colonize the ileum via host-specific F18 
fimbriae that allow the bacteria to adhere to F18 receptors on small intestinal enterocytes (Coddens et al., 
2009). The F18 fimbria has been also indicated as an important virulence factor related to OD, and pig 
intestinal colonization with live (F18-positive) Escherichia coli strains resulted in a significantly increased 
level of anti-fimbriae antibodies, especially IgA, in serum and intestinal wash fluids (Sarrazin and 
Bertshinger, 1997). Colonization is followed by secretion of verotoxins responsible for the pathogenic effect.  
Currently, no vaccine that protects piglets against OD is available and treatment relies upon the use of 
antimicrobials that, however, are frequently used too late for piglets with visible clinical signs, when the 
toxin has already been produced in the gut, has systemically spread and caused consequent lesions. 
Moreover, due to the excessive use of antibiotics in intensive and large-scale swine production and due to the 
consequent increase of antibiotic-resistant enteric bacteria, especially E. coli strains, treatment with 
antimicrobials has come under increased scrutiny (Aarestrup et al. 2008).  
Due to the pathogenesis, oral vaccination could represent an interesting strategy to control the disease. In fact 
oral delivery of antigens has shown to be capable to induce mucosal immune responses (Cox et al., 2002). 
The mucosal immune system plays a crucial role in the primary defence against pathogens that invade the 
gastrointestinal tract, by preventing adhesion of the pathogens and/or neutralizing toxins (Streatfield et al., 
2006). 
The use of transgenic plants as delivery system for antigenic proteins is attractive for its simplicity and 
increases likelihood for local immune response at sites of infection. Plant as edible vaccine present many 
potential advantages related to the management of intensive livestock because they can be administered in 
the feed without having to restrain the animals, which is both less stressful for the animals and reduces labour 
costs in terms of the multiple injections of traditional vaccines no longer being needed (Pinotti et al., 2003; 
Widgorovitz et al., 1999). 
In this study the attention was focalized on tobacco seeds expressing the FedA, the major protein of F18 
fimbriae, responsible for the adherence of the bacteria on small intestinal enterocytes, and the B subunits of 
VT2e, responsible for binding the toxin to specific receptors on cell surface. Previous studies demonstrated 
that the Vt2e-B and FedA fimbrial genes were stably incorporated into tobacco plant genome by being 
transcribed through the nuclear apparatus of the plant for specific expression in the seeds, and that these 
genes are inherited by the next generation (Rossi et al.,2003a). Mice can be stimulated to produce mucosal 
antibodies after oral administration of recombinant tobacco seeds for the expression of F18 and VT2e-B 
antigens (Rossi et al.,2003b; Rossi et al., 2013a). Moreover, tobacco seeds, unlike the leaves, do not contain 
significant levels of nicotine and, once included in diets for weaned piglets, they showed a good palatability 
(Rossi et al. 2007) and can use as alternative protein source (Rossi et. al 2013b). For these reasons, the aim of 
this study was to evaluate whether oral administration transgenic tobacco seeds expressing antigenic proteins 
from verocitoxic E.coli strain can have a protective effect against a subsequent O138 Escherichia coli 
challenge in piglets. 
 
 
 
 Materials and methods 
 
Animals, facilities and feeding 
 
Forty-three piglets (Landrace x Large White) were selected from a conventional herd free from diseases 
according to the A-list of the International Office of Epizootic, and from Aujeszky’s disease, atrophic 
rhinitis, transmissible gastroenteritis, porcine reproductive and respiratory syndrome and salmonellosis, 
without history of PWD and OD and with bacteriological analysis of the faeces negative for hemolytic E. 
coli. Piglets were early weaned at 20±2 days to ensure the animals' sensitivity upon experimental infection 
and were transported to the experimental facilities specific for pigs at the Experimental Animal Research and 
Application Centre in Lodi of the University of Milan. 
Animals were allocated in pens, each pen containing 2-3 piglets, under the same environmental conditions 
(environmental temperature regulated at 28 °C and relative humidity maintained at 60%), with water and 
feed ad libitum. The composition of the experimental diet is reported in Table 1.  
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Table 1 – Composition of the experimental diet and calculated chemical analysis 
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The pigs were orally treated with colistine (150,000 units/kg body weight/day) up to 5 days post-weaning to 
prevent E. coli infections. Experimental and management procedures were approved by the Ethics 
Committee of the Faculty of Veterinary Medicine (Favourable opinion about the project “Evaluation of 
immunogenity of tobacco seeds expressing antigenic protein to OD in weaned piglets”, February 17th, 2011). 
 
 
Production and Chemical analyses of tobacco seeds 
 
Six homozygous transgenic lines of tobacco (Nicotiana tabacum L., cv. Xanthi), three harbouring 
respectively  the Vt2e-B gene and three the  FedA subunit of F18 fimbriae gene, previously obtained (Rossi 
et al., 2003a; Rossi et al., 2013a), were cultivated in a greenhouse in homogeneous environmental conditions 
(at 15°C night and 25°C day temperature). In particular, a total of eighty F18 positive plants and one hundred 
and forty VT2eB positive plants, derived from the selected homozygous transgenic plants were cultivated in 
a grennhouse of Plantechno s.r.l. in a period of 14 months. Each plant grew in individual vessel filled with 
peat of the same humidity and nutrient’s content. No differences were observed in relation to the yield of 
seeds among the experimental lines of tobacco plants (about 7-15g of seed per plant). A total amount of 500 
grams of transgenic tobacco seeds transformed for the expression of FedA, the major protein of the F18 
adhesive fimbriae (F18TS), and 1,900 grams of transgenic tobacco seeds transformed for the expression of 
VT2eB (VT2eBTS), expressing about 0.6mg of heterologous protein per gram of seed were used as 
experimental treatments. Wild type tobacco seeds were administered to controls.  
Transgenic and wild type tobacco seeds used in the present study were ground with a suitable mill to obtain a 
uniform milling, paying attention to avoid the overheating of the seeds and the subsequent proteins 
denaturation (Rossi et. al., 2011). 
The chemical analysis of tobacco seeds was performed to measure the principal components: dry matter (dm, 
AOAC method 930.15); crude protein (CP, AOAC method 2001.11); ether extract (EE, DM 21/12/1998); 
crude fibre, (CF, AOCS method Ba 6a-05); neutral detergent fibre, (NDF, AOAC method 2002.04) and ash 
(AOAC method 942.05). 
 
 
Groups and treatments 
 
Piglets were randomly divided into four experimental groups. Treatment 1 group (T1) was composed of 12 
piglets, receiving 20 grams of milled transgenic tobacco seeds (10 grams VT2eBTS and 10 grams F18TS). 
Treatment 2 group (T2) was composed of 9 piglets, receiving 10 grams of milled VT2eBTS. Treatment 3 
group (T3) was composed of 10 piglets, receiving 25 grams VT2eBTS. Control group (CG) was composed of 
12 piglets, receiving 20 grams of wild type milled tobacco seeds. 
Piglets were fed tobacco seeds on 0,1,2 and 14 days post primary administration (dppa). Day 0 was 
considered the 5th day after the weaning. Tobacco seeds were individually administered mixed with chocolate 
and water in palatable boluses. Three hours before the oral administration up to 3 hours after it, animals were 
deprived of food. About 10-15 min before each administration piglets orally received 60 mL of a 10% 
bicarbonate solution to neutralize the gastric acid pH and to protect the antigen against possible denaturation 
(Snoeck et al., 2004). 
  
Experimental infection 
 
O138 Escherichia coli strain, isolated from weaned piglet that had died because of OD was used as challenge 
strain. The challenge strain was evaluated, in order to verify the presence of VT2e and F18 genes, by PCR 
assay using the following experimental conditions.  
The volume of all reaction mixture was 50 µl, with 5 µl of template (bacterial DNA) added to PCR mixture. 
Primers 5’ – ggATCCATgAAAAgACTAgTgTTTATTTCTTTTg and 3’ 
gAgCTCTTACTTgTAAgTAACCgCgTAAgC were used for f18 adhesive fimbriae gene detection. Cycling 
conditions consisting of a hot star at 94°C for 3 min followed by 94°C for 1 min, 56°C for 1min 20secs, 72°C 
for 1 min 30 sec, and a ﬁnal extension step of 72°C for 5 min.  
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Primers 5’ – ggATCCATgAAgAAgATgTTTATAgCgg and 3’ gAgCTCTTAgTTAAACTTCACCTgggCAA 
were used for B subunit of VT2e toxin gene detection. Cycling conditions consisting of a hot star at 94°C for 
3 min followed by 95°C for 1 min, 50°C for 1min, 72°C for 1 min 30 sec, and a ﬁnal extension step of 72°C 
for 5 min. PCR assays was carried out with GeneAmp thermal cyclers (Applied Biosystems, Carlsbad, CA) 
for 25 cycles.   
About one week after booster administration (22 dppa), the animals were orally challenged with O138 
Escherichia coli strain grown in broth medium. Sixty minutes before challenge, piglets were sedated with 
azaperon (StresnilTM, Janssen Cilag SpA, 2 ml/head), thereafter 30 mL of a 10% bicarbonate solution 
(SIGMA, Italy) was orally administered in the attempt to neutralize gastric acid and to increase the survival 
rate of challenger strain in the stomach (Madec et al., 2000, Jensen et al., 2006). After 10-15 min, the 
inoculum was given via oral route in a single dose of 5 mL of bacterial medium with 1*1010 colony forming 
units (CFU) of challenger strain, using 16G catheter. Animals were fasted 3 hours before and 3 hours after 
challenge.  
For each group, two animals were not challenged and housed in pens separated by means of two empty pens 
from the infected group, so that physical contact between challenged and not challenged piglets was 
excluded. 
From the day of challenge until the second day after challenge, the same antimicrobial-free diet, containing 
27% of crude protein on dry matter, was administered to all experimental groups. Before administration, 
chemical analysis of the diet was performed to confirm its high protein level and to measure its principal 
components: crude protein (CP), according to the official method of Analysis of Association of Analytical 
Communities, procedure 2001.11 (AOAC, 2005); dry matter (dm), according to procedure 930.15 (AOAC, 
2005); fat (EE) according to DM 21/12/1998; crude fibre (CF), according to procedure Ba 6a-05 of the 
official method of the American Oil Chemists Society (AOCS, 1998); ash, according to procedure 942.05 
(AOAC, 2005). 
 
Data and sample collection  
 
Blood was collected from the jugular vein of each animal on 0, 7, 14, 21, 25, 29 and 36 dppa. Samples were 
taken in double to determine hematocrit value and serum antibodies, as described below. Faecal samples 
were taken from rectum weekly on 0, 7, 14, 21 dppa to determine total IgA levels in the immunization phase, 
as described below. From the day of challenge until day 14 post-challenge (36 dppa), rectal temperature was 
daily recorded and the clinical signs of the disease according to point scale score described by Tsukahara et 
al. (2006). In particular: palpebral oedema, epiphora, vitality, respiratory and neurological problems - were 
daily checked and scored using the specific point scales reported below. Respiratory score: 0=normal; 
1=slightly quick; 2= quick.; Oedemal score in palpebra: 0=normal; 1=mild; 2=severe; Epiphora score: 
0=normal; 1=mild; 2=severe; Vitality score: 0=good; 1=loose; 2=bad. 
In the same period, faecal consistency was daily evaluated through a scale of four levels: 0=normal faeces; 
1=soft consistency 2=mild diarrhoea; 3=severe diarrhea (Rossi et al., 2012).  
All piglets were individually weighed weekly during the entire experimental period and twice in the week 
following challenge (25 and 28 dppa); the feed intake (FI) was daily measured weighing the residual feed at 
the pen level (experimental unit for FI evaluation).  Animal care and euthanasia at the end of the trial were 
conducted in accordance with the European Union guidelines (86/609/EEC) approved by the Italian Ministry 
of Health.  
 
Antibodies immunoglobulin A (IgA) and immunoglobulin G (IgG) quantification in faeces and serum 
samples 
 
In order to separate antibodies from faecal content, 0.5 g of stool was diluted in 1 ml of sterile water and 
thoroughly mixed for 1 hour. Two ml of PBS-Tween 20 were added to 1 g of the homogenate and 
centrifuged at 1,600 × g for 15 min at 4°C. The supernatant was collected and further centrifuged at 7,200 × g 
for 10 min at 4°C. The supernatant was then removed and stored at −20°C until use. 
Stool samples were diluted 1:100 for quantification of IgA and used without further processing for the 
quantification of IgG. Serum samples were diluted 1:5,000 for titration of IgA and 1:20,000, using serial 
dilutions in PBS and Sample Diluent, for titration of IgG . Total IgA and IgG concentrations in serum and 
faecal samples were evaluated through Pig ELISA IgA and IgG quantitation set (Bethyl Laboratories, Texas). 
Microtitration 96-well plates were coated for 1 h at ambient temperature (20-25°) with 100μl of a solution 
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containing 1 μl of affinity purified anti-Pig IgA (or IgG)  coating antibody diluted in 100 μl of coating buffer. 
After aspiration of the antibody solution and after washing the plate, the wells were blocked with 200 μl of 
Blocking Solution for 30 minutes and then washed five times with 300 μl of Wash Solution. To each well 
100 μl of standard or sample were added and incubated at room temperature for 1 hour. 100 μl of diluted 
HRP detection antibody were added to each well and incubated at room temperature for 1 hour. After 
washing  100 μl of TMB Substrate Solution were added to each well. The plate was developed in the dark at 
room temperature for 15 minutes, then reaction was stopped by adding 100 μl of Stop Solution to each well. 
Absorbance was measured on a plate reader at 450 nm. For each plate, a standard curve was constructed to 
calculate the IgA or IgG concentration of each sample using “Curva Expert 1.3” software. The concentrations 
determined were expressed as nanograms of IgA or IgG per 1 ml.  
 
 
Microbiological analysis of faecal samples 
For each sample 1 gram of faeces was homogenized with 1 ml of saline and incubated overnight at 37 ° C on 
sheep blood agar plates 5% (Blood Agar Base No. 2 - Oxoid), to examine the presence of hemolytic colonies. 
Up to 5 hemolytic colonies were selected from each plate and growth on MacConkey agar (MacConkey Agar 
- Oxoid), Triple Sugar Iron (Triple Sugar Iron Agar - Oxoid), citrate (Simmons Citrate Agar - Oxoid) and 
peptone water (Oxoid Buffered Peptone Water). Colonies positive for glucose oxidation–fermentation, 
fermentation of lactose (MacConkey agar), indole production (peptone water + reagent Kovacs - Kovac's 
reagent for indoles-Fluka) and sodium citrate-negative were then subjected to confirmatory biochemical test 
strips with the API system (API 20 NE-Biomerieux). 
 
Statistical analysis 
 
Data were analysed using the GLM procedure (SAS System, Version 9.2; SAS Institute, Inc., Cary, NC).  
For the performance data, Average Daily Gain (ADG), Average Daily Feed Intake (ADFI) and Gain-to-Feed 
Ratio (G:F) were averaged over a pre-challenge period (0-21 dppi) and 3 post-challenge periods (21-25, 25-
28 and 21-28 dppi), in order to evaluate the effect of E. coli infection on the zootechnical performances of the 
experimental groups. 
In the experiment, pen means were treated as the experimental unit for daily feed intake measurement. All 
other measurements were assessed using the individual pig as experimental unit. The values are represented 
by means ± sem. 
 
Results  
 
The chemical analysis of principal components of the tobacco seeds is reported in Table 2. No differences in 
the analytical composition were observed between transgenic seeds and wild-type seeds.  
 
Table 2 – Analytical composition of tobacco seeds. 
Chemical composition  
 % DM % as fed  
CP, %  23,71  22,79  
Fat, %   35,35  33,97  
NDF, %  43,2  41,51  
Ash %  2,81  2,7  
 
PCR assay, on different clones of O138 Escherichia coli strain, confirmed the presence of virulence factors: 
the VT2e toxin and the F18 adhesive fimbriae genes.  PCR products putatively encoding the B-subunit of 
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VT2e and F18 fimbriae were identified on agarose gel (1.5% - 0.9%) as bands with a length of 270 and 519 
basepairs, respectively (fig. 1,2).  
 
Fig. 1: Agarose gel (1,5%) one-dimensional electrophoresis of PCR products for the detection of VT2e-B 
gene from genomic DNA of O138 Escherichia coli challenge strain.  
Lane 1: marker 250 pb; lanes 2–6: positive samples; lane 7: negative sample from non pathogenic BL21 
Escherichia coli strain.  
 
 
 
 
Fig 2: Agarose gel (0.9 %) one-dimensional electrophoresis of PCR products for the detection of F18 gene 
from genomic DNA of O138 Escherichia coli challenge strain. 
Lane 1: marker; lanes 2–6: positive samples; lane 7: negative control represented by genomic DNA from non 
pathogenic BL21 Escherichia coli strain; lane 8: marker 1kpb. 
 
 
 
Chemical analysis of the experimental diet administered from the day of challenge until the second day after 
challenge confirmed the high level of protein previously calculated by Plurimix software (CP 27.46% dm, EE 
5.38% dm, CF 6.73% dm, ashes 5.54% dm).  
From the day after challenge, clinical signs related to VTEC infection were observable in infected piglets. 
Clinical and faecal scores related to VTEC infection, such as palpebral oedema, epiphora, loss of vitality and 
respiratory problems, in all challenged groups from the day after challenge until day 9 post-challenge are 
shown in Table 3.  
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Table 3 – Average score of clinical signs of OD in challenged piglets. VTEC challenge was performed on 
day 0. T1: piglets orally immunized with 6 mg of F18 and 6 mg of VT2e-B; T2: piglets orally immunized 
with 6 mg of VT2e-B; T3: piglets orally immunized with 15 mg of VT2e-B; Control: piglets receiving wild 
type tobacco seeds. 
Respiratory score: 0=normal; 1=slightly quick; 2= quick. 
Oedemal score in palpebra: 0=normal; 1=mild; 2=severe. 
Epiphora score: 0=normal; 1=mild; 2=severe. 
Vitality score: 0=good; 1=loose; 2=bad. 
Faecal score: 0=normal faeces; 1=soft consistency 2=mild diarrhoea; 3=severe diarrhoea. 
Total score is the sum of the average daily scores from day 22 to day 30 (post-challenge period). 
One-way ANOVA was used for multiple comparisons. Means in a column without common letters are 
significantly different (P<0.05) 
 
Neurological signs and death were not observed in any pigs throughout the experiment. T1 group presented 
the lowest values on a daily basis, showing a maximum average daily score (0.6) on day 5 post-challenge. In 
particular, focusing on palpebral oedema, more closely related to the disease than other symptoms, the 
control group presented the highest average daily scores, showing an average score >0.9 from day 2 to day 6 
post-challenge. T1 group presented the lowest values on a daily basis, showing a maximum average daily 
score (0.6) on day 5 post-challenge. As to vitality, considered symptom of general well-being, was better in 
treated piglets compared to controls on a daily basis. Once again, subjects in T1 group showed a better state 
of health and were more reactive to stimuli. For each clinical sign, the average total score, i.e. the sum of 
  Days 
(post challenge) Total score 
Challenged 
piglets 
Total score 
Unchallenged 
piglets 
Scores Group 22 23 24 25 26 27 28 29 30 
 
 
Respiration Contr 0,6 0,4 0,6 0,7 0,4 0,4 0,7 0,5 0,5 4,8a 0.2 
 T1 0,3 0,2 0,3 0,2 0,1 0,2 0,3 0,3 0,0 1,9 b 0.1 
 T2 0,3 0,1 0,3 0,3 0,3 0,1 0,4 0,4 0,1 2,4 b 0.2 
 T3 0 0,1 0,1 0 0,1 0,3 0,4 0 0,0 1,0 b 0.1 
Palpebral 
edema 
Contr 0,6 1,1 1,0 1,0 0,9 1,0 0,6 0,8 1,0 8,0 a 0 
 T1 0,2 0,2 0,4 0,1 0,6 0,4 0,0 0,0 0,0 1,9 c 0 
 T2 1,0 0,6 0,9 0,3 0,0 0,6 0,0 0,3 0,7 4,3 b 0 
 T3 0,8 0,5 0,5 0,3 0,1 0,3 0,1 0,1 0,0 2,6 c 0.1 
Epiphora Contr 0,2 0,4 0,9 1,0 0,5 0,5 0,4 0,8 0,4 5,1 a 0.3 
 T1 0,3 0,3 0,2 0,2 0,2 0,3 0,1 0,2 0,6 2,4 b 0.1 
 T2 0,1 0,4 0,6 0,3 0,0 0,3 0,1 0,1 0,3 2,3 b 0.1 
 T3 0,0 0,3 0,5 0,0 0,0 0,3 0,1 0,0 0,0 1,1 b 0.8 
Vitality Contr 0,9 0,6 0,6 0,8 0,7 0,6 0,4 0,6 0,5 5,7 a 0 
 T1 0,5 0,2 0,0 0,1 0,0 0,1 0,0 0,0 0,0 0,9 b 0.1 
 T2 0,6 0,4 0,1 0,1 0,3 0,4 0,4 0,0 0,1 2,6 b 0.2 
 T3 0,6 0,5 0,4 0,1 0,1 0,1 0,1 0,0 0,0 1,9 b 0.5 
Faecal score Contr 1,1 1,2 1,8 1,3 0,8 0,7 1,1 1,1 0,5 9,5 ab 7.3 
 T1 1,0 1,3 1,0 0,8 0,5 0,4 0,5 0,4 0,3 6,1 b 4.3 
 T2 1,6 2,0 1,9 1,0 1,3 1,6 1,9 1,1 0,7 13,0 a 6.0 
 T3 1,8 1,9 1,9 1,3 1,3 1,4 1,4 1,0 0,6 12,4 a 3.0 
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average daily scores from day 1 to day 9 post-challenge, was significantly higher in the control group 
compared to orally immunized groups (T1, T2 and T3, P<0.05).  
A slightly different situation was found when evaluating faecal scores; in this case, T1 group showed scores 
significantly better compared to T2 and T3 groups (P<0.05). From day 9 onwards, in all challenged groups 
the average clinical and faecal score returned within the range of normality. A slight increase in average 
temperature was measured in all groups after challenge (fig.4).  
 
 
Figure 4 – Average rectal temperature in challenged groups. VTEC challenge was performed on day 0. 
T1: piglets orally immunized with 6 mg of F18 and 6 mg of VT2e-B; T2: piglets orally immunized with 6 mg 
of VT2e-B; T3: piglets orally immunized with 15 mg of VT2e-B; Control: piglets receiving wild type 
tobacco seeds. 
 
 
 
 
 
 
However, average temperature and hematocrit percentage did not show significant differences among 
experimental groups. 
Piglets, at the beginning of the experiment (day -5), had an average individual body weight of 5.5 ± 0.27, 5.5 
± 0.39, 5.7 ± 0.15, 5.5 ± 0.5 kg (lsmeans±SE) for control, T1, T2 and T3 group, respectively (table 4). 
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Table 4 – Growth performance of experimental groups after E. coli infection. VTEC challenge was 
performed on day 21.T1: piglets orally administered 10g F18TS and 10g VT2e-BTS; T2: piglets orally 
administered 10g of VT2eBTS; T3: piglets orally administered 25g of VT2eBTS; Control: piglets receiving 
wild type tobacco seeds.Items were described in  challenged (+) and unchallenged (-)animals.Values with 
different superscript letters in the same row indicate significant difference (P<0.05).BW: body weight; ADG: 
average daily gain; ADFI: average feed intake; G:F: Gain-to-Feed Ratio. 
 
During the immunization period (0-21 dppi), after an initial phase of adaptation to the solid diet, in which 
feed intake and weight gains were low (from day -5 to day 0), the average daily gain (ADG) and average 
dialy feed intake (ADFI) were in line with the standards of growth of the piglets in this phase, with no 
statistically significant differences among the experimental groups (ADG,g 0-21 dppi: control: 308±29; T1: 
346±29; T2: 358±34; T3: 310±32; ADFI,g 0-21 dppi: control: 386±24; T1: 413±22; T2: 527±34; T3: 
396±16). 
In the first post-challenge period (21-25dppa) infected piglets in all experimental groups showed a reduced 
average daily gain compared to  pre-challenge period, which was more evident for control groups and T3 
group compared to others. 
In addition, during 21-28 dppi, non-infected control and T3 groups showed higher ADFI (control: 568 g1 T3: 
701 g1) and non-infected control, T2 and T3 groups showed higher ADGs (control: 432±160 g; T2: 357±14 
g; T3: 593±100 g) compared to the corresponding infected groups.  
The performance of T1 not infected group (Average Daily Feed Intake 21-28: 497 g; Average daily gain 21-
28: 357±21 g; Gain-to-Feed Ratio 21-28: 0.72) were very similar to those of T1 infected group.  
Comparing the performance of infected groups among them, shortly after challenge (21 -25 dppi) T1 and T2 
groups showed higher ADGs than the other groups and significantly higher ADFI compared to control 
(P<0.05).During the following period (25-28 dppi) an increased ADG and ADFI was observed in all infected 
groups, to a greater extent in group T1. 
                                         
 
Item  Control T1 T2 T3 P Challenge 
BW       
day 21, kg 11.79±0.871 13.39±0.571 14.61±0.442 12.09±0.619 - + 
day 28, kg 13.62±1.20 16.08±0.543 16.54±0.858 13.93±0.903 - + 
day 21, kg 14.53±1.87 13.45±2.26 10.30±1.70 14.40±3.61  - 
day 28, kg 17.75±3.46 15.95±2.05 12.80±1.84 18.55±4.60  - 
ADG, g       
d 21 to 25 131±64 228±64 214±76 128±72 0.613 + 
d 25 to28 433±104 593±104 355±124 442±116 0.496 + 
d 21 to 28 261±55 384±55 274±66 263±61 0.352 + 
d 21 to 25 356±293 300±50 150±12 481±18 - - 
d 25 to28 533±16 433±16 633±50 742±208 - - 
d 21 to 28 432±160 357±21 357±14 593±99 - - 
ADFI, g       
d 21 to 25 390±22a 463±24 b 487±26 b 416±24 ab 0.31 + 
d 25 to28 535±36 ab 596±40 b 516±43 ab 467±40 a 0.180 + 
d 21 to 28 444±24 513±27 497±29  435±27 0.131 + 
d 21 to 25 501± 32 432±45 434±27 625±24 - - 
d 25 to28 681±39 607±39 563±35 826±40 - - 
d 21 to 28 568±34 497±42 483±33 701±35 - - 
G:F g/g       
d 21 to 25 0,33±0.12 0,54±0.13 0,49±0.15 0,26±0.13 0.438 + 
d 25 to 28 0,81±0.20 0,86±0.23 0,30±0.26 0,95±0.23 0.305 + 
d 21 to 28 0,58±0.08 0,70±0.09 0,49±0.10 0,59±0.9 0.466 + 
d 21 to 25 0,71±0.08 0,69±0.21 0,35±0.12 0,77±0.42 - - 
d 25 to 28 0,78±0.7 0,71±0.16 1,12±0.13 0,90±0.11 - - 
d 21 to 28 0,76±01 0,72±0.09 0,74±0.23 0,85±0.13 - - 
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Overall, the T1 challenged group, that showed a better clinical presentation after challenge, showed also the 
best performance data, considering Average Daily Gain (ADG), Average Daily Feed Intake (ADFI) and 
Gain-to-Feed Ratio (G:F), among the infected groups in the post-challenge period (21-28 dppi).  
From the moment of primary oral administration (0 dppi) to 7 dppi a decline of total IgA levels was 
observed. One week following the fourth administration (booster immunization), the day before challenge 
(21 dppi), mean IgA faecal levels were increased and were higher in the T1 group, compared to the others 
(22,000±13,000 ng/ml vs control group: 7,200±3,000 ng/ml) (fig.3). 
 
Figure 3 – Mean faecal IgA levels of piglets orally immunized with transgenic tobacco seeds containing 
about 6 mg of F18 and 6 mg of VT2e-B (T1), with transgenic tobacco seeds containing about 6 mg of VT2e-
B (T2), with transgenic tobacco seeds containing about 15 mg of VT2e-B (T3) and with wild type tobacco 
seeds (Controls) in the pre-challenge period. SE of each point is indicated. 
Black arrows represent immunization and white arrow the VTEC challenge. 
 
 
 
 
With regard to IgG levels in the faeces, statistically significant differences among experimental groups were 
not detected. Considering the general trend over the time, with the exception of day 0, when a high title was 
recorded due to maternal transfer of immunity, in the rest of the pre-challenge period faecal IgG levels kept 
almost constant in all groups. The IgG was present in very low quantities in the faeces compared with IgA, in 
agreement with data reported by other authors (Franz and Corthier 1981).  
Total IgA and IgG serum levels monitored in the pre-challenge period showed no significant differences 
among experimental groups.  
 
None of the piglets presented faecal shedding of hemolytic E. coli strains before challenge. 
Microbiological evaluation of faecal samples showed presence of hemolytic E. coli strains one day after 
challenge (23 dppi), in almost half of the subjects of each group (41.67% of piglets in control group, 50% in 
T1 group, 33.33% in T2 group and 40% in T3 group). The microbiological analysis confirmed the effect of 
the challenger strain on faecal shedding of hemolytic E. coli strains. The detection of the E. coli strain from 
the faeces did not invariably correspond to the presence of diarrhoea; this finding is consistent with the 
clinical features of the disease; in fact diarrhoea is not considered a typical clinical sign of OD. 
From 23 dppi to 28 dppi, in some subjects of each group a steady but intermittent faecal shedding of 
hemolytic E. coli strains was observed. 
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Discussion and Conclusions 
 
The weaning transition is a particularly complex period, during which the piglets are confronted by multiple 
stressors. The immediate effect of weaning is a dramatic reduction in feed intake and a consequent ‘growth 
check’, which continues to represent a major source of production losses in commercial piggeries. Weaning 
also causes alterations in intestinal architecture and function, predisposing to diarrhoea and intestinal 
infections, particularly from E. coli strains. VTEC strains are important causes of diarrhoea, growth 
retardation and mortality in piglets during the first weeks after weaning. Up to now, no vaccine protecting 
piglets against these infections is available and treatment relies upon the use of antimicrobials. Before 2006, 
antibiotic growth-promoters were widely used, added to feed for piglets from birth to weaning, with the aim 
of improving the composition of intestinal microflora in piglets and of reducing enteric infections. Due to the 
fact that the use of antibiotics as growth promoters has been banned in the EU, intensive research has focused 
on the development of alternative strategies for prevention of these infections in weaned piglets.  
This study was focused on the evaluation of a protective effect of oral administration transgenic tobacco 
seeds expressing antigenic proteins from verocitoxic E.coli strain, was to set-up experimental immunization. 
The main problem related to the oral administration of antigens is the degradation in the gastrointestinal tract.  
The production of antigens in seeds has the advantage of a natural encapsulation in the tissues of the 
expression host. This encapsulation offers the potential for antigen to be protected against rapid and complete 
degradation and to be gradually released as host tissues are igested (Bailey, 2000). Neverthless the oral 
administration of whole transgenic tobacco seeds in newly-weaned piglets raises doubts about an effective 
exposure of the antigen to the sites of activation of the mucosal immune system. So according to a previous 
study (Rossi et al., 2011) the use of milled transgenic tobacco seeds would appear more appropriate for 
animals with immature digestive capacity. 
Moreover oral delivery of antigens can offer the potential to mount an immune response to a pathogen at the 
site of invasion, so providing a first line of defense against infection. In the immunisation phase, the amount 
of antigen used for oral administration was determined after a thorough literature search, considering the 
doses used by other researchers (Verdonck et al. 2007, Lamphear et al. 2002, Streatfield et al. 2001). In the 
present study two proteins actively involved in different parts of the pathogenic process of OD were chosen 
as antigens for oral immunization of weaned piglets: FedA, the major protein of the F18 adhesive fimbriae, 
the primary pathogenic factor, responsible for the adhesion of E. coli strains to enterocyte receptors; and the 
B subunit of VT2e, responsible for receptor binding capacity of the toxin and consequent systemic damage.  
O138 Escherichia coli challenge strain showed important virulence characteristics, represented by F18 
adhesive fimbriae gene and verocitoxin gene, confirmed by PCR analyses. Neverthless Escherichia coli 
infection are multifactorial disorders and experimental infection with E. coli alone is not sufficient to 
reproduce the syndrome as observed in the field (Rossi et al., 2012).  In this study, factors predisposing the 
piglets to the clinical signs were introduced into the experimental challenge model, including an iperproteic 
diet and bicarbonate solution orally administered with purpose to neutralize gastric acid and to increase 
gastric survival rate of the challenger strain.  The diet administered during the first three days, containing a 
high level of crude protein, was intended to be a “high-risk” diet, since several pathogens preferentially 
ferment proteins and high amounts of crude protein in the diet of newly weaned piglets have been identified 
as one of the predisposing factors of Escherichia coli diseases.  
The experimental infection, while having caused no mortality or neurological symptoms, was effective in 
reproducing the typical symptoms of the disease and led to intestinal colonization by E. coli strains, as 
demonstrated by the faecal shedding of hemolytic E. coli in almost half of the subjects of each group, as 
detected one day after challenge (23 dppi). 
Clinical examination after challenge thus suggested a possible protective effect of immunization with VT2eB 
antigen against systemic symptoms induced by toxin VT2e, as well as a protective effect at gastrointestinal 
mucosal level from immunization with FedA antigen. All groups orally immunized with VT2eB antigen (T1, 
T2, T3) showed mild clinical signs of VTEC infections compared to the control group, and the group orally 
immunized with both VT2eB and FedA antigens (T1) proved also a better faecal score compared to others.  
This may indicate that vaccination with both antigens probably conferred a protective effect at 
gastrointestinal mucosal level as well. 
Overall, a better clinical presentation was observed after challenge in piglets of T1 group, immunized with 
transgenic tobacco seeds containing both antigens (VT2eB and FedA). This immunization strategy appeared 
more effective in preventing the development of clinical signs after challenge with O138 E. coli strain. 
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As expected, the zootechnical parameters were clearly affected by the experimental infection, especially in 
the phase immediately following challenge (21-25 dppi), confirming the negative impact of the experimental 
VTEC infection on zootechnical performances.  
 
The T1 challenged group, with a better clinical presentation after challenge, showed also the best 
performance data (Average Daily Gain, Average Daily Feed Intake and Gain-to-Feed Ratio) among the 
infected groups during post-challenge period (21-28 dppi). Performance of this group was also very similar to 
that of the corresponding non infected group, suggesting that E. coli infection had no effect on average daily 
gain  and feed intake of the group orally immunized with both VT2eB and FedA antigens.   
The use of the multicomponent (T1) vaccine again appeared more effective in preventing the negative impact 
of challenge with O138 E. coli strain. For all measured parameters, no differences were observed between T2 
and T3 groups, suggesting that no dose-response effect was shown for the Vt2e-B antigen in our 
experimental conditions.  Moreover, the oral immunization itself had no negative effects on production, as no 
significant differences in body weight and daily weight gain have been observed between control and 
immunized piglets. 
In our experiment (Figure 4), from the moment of primary oral administration (0 dppi) to 7 dppi a decline of 
total IgA levels was observed, consistently with the rapid decline of luminal level of sIgA observed a few 
days after weaning (Ushida et al. 2008). Secretory immunoglobulin A (sIgA) is a protective molecule of the 
mucosal immune system (Snoeck et al. 2006). It mediates the primary immunological defense line in the 
mucosal immune system. In the case of pigs, maternal sIgA is supplied to piglets by maternal colostrum and 
milk. Faecal IgA detected before 10 days of life is likely to be mostly derived from maternal fluids ingested 
during the first 3 days and IgA detected after 22 days to be produced by the piglet (Thompson et al., 2008). In 
piglets, the key elements of the induction system in the mucosa develop over the first 2 weeks after birth and 
an almost adult organization of Peyer's patches is typically present by 12 days (Bailey et al., 2001). The final 
stage of pig immune system maturation is thought to start around 28 days of age, when the CD8+ T cells 
infiltrate the intestinal tissue, and the mucosal immune system has a largely adult architecture by 6 weeks of 
age (Bailey et al., 2001). At this age, IgA-secreting plasma cells are also present in the intestine (Bianchi et 
al., 1999). Our results showed, one week following booster immunization (21 dppi), a higher faecal IgA titre 
in T1 group, receiving both antigens, compared to others, which is probably related to a higher specific, but 
also aspecific, local immune response activity in this group (Fritz at al. , 2012). Althought the increased 
levels of faecal IgA observed in T1 group may suggest a higher local immune response activity in the group 
immunized with both antigens we didn’t observe differences statistical significant.The lack of significance of 
this finding is probably due to the large intra-individual variation in faecal immunoglobulin levels observed 
in our experiment, higher than that observed in preliminary studies performed on a mouse model (Rossi et al., 
2003b). In conclusion, the results of this study suggest that oral administration of transgenic tobacco seeds 
expressing FedA,the major protein of the F18 adhesive fimbriae, and VT2eB antigens may induce a 
protective effect against O138 E. coli infection. In particular, better results were obtained by the use of the 
multicomponent vaccine, based on two important virulence factors of VTEC strains. Transformed tobacco 
plants for seed-specific expression of genes encoding FedA protein and VT2e-B subunit of shiga-like toxin 
may represent a promising non-invasive method of vaccinating swine via their feed.  
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